Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up

Graham S Hillis1, Bernie L Croal, Keith G Buchan

  • 1Department of Cardiology, University of Aberdeen, Aberdeen Royal Infirmary, UK. g.hillis@abdn.ac.uk

Circulation
|February 24, 2006
PubMed

Insights

Estimated glomerular filtration rate (eGFR) predicts mortality after coronary artery bypass graft surgery (CABG). Lower eGFR indicates a higher risk of death, making it a valuable tool for assessing patient outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Surgical Outcomes

Background:

  • Severe kidney dysfunction worsens outcomes after coronary artery bypass graft surgery (CABG).
  • Previous studies used serum creatinine, an insensitive marker of kidney function.
  • Estimated glomerular filtration rate (eGFR) may be a more accurate measure for predicting outcomes.

Purpose of the Study:

  • To evaluate the utility of eGFR in predicting mortality after CABG.
  • To determine if eGFR is a better predictor than traditional risk scores.

Main Methods:

  • Studied 2067 patients undergoing CABG.
  • Calculated eGFR using the Modification of Diet in Renal Disease equation.
  • Followed patients for a median of 2.3 years to assess all-cause mortality.

Main Results:

  • Mean eGFR was lower in patients who died (57.9 mL/min/1.73 m2) compared to survivors (64.7 mL/min/1.73 m2).
  • eGFR was an independent predictor of mortality (HR 0.71 per 10 mL/min/1.73 m2, P<0.001).
  • eGFR remained a significant predictor even when included in risk models (HR 0.80, P<0.001; HR 0.88, P=0.02).

Conclusions:

  • Estimated glomerular filtration rate (eGFR) is a powerful predictor of mortality after CABG.
  • eGFR provides valuable prognostic information beyond traditional risk factors.
Abstract